News & Updates

In regions where there is high antibiotic resistance of Helicobacter pylori (H pylori), the best options in treatment-naïve patients include the 3-in-1 single capsule, bismuth quadruple therapy, and concomitant regimen with tinidazole, suggests a study. In non-naïve patients, the 3-in-1 single capsule and the triple therapy with levofloxacin offers adequate eradication.

Although the COVID-19 pandemic is over, the disease remains a threat as it is predicted to become a significant danger to public health in the next 2 years, particularly in the US, according to a study. Wide-ranging vaccination, however, can counter this potential problem.

Antenatal exposure to corticosteroids, particularly betamethasone, does not increase the prevalence of cardiovascular risk factors or the incidence of major adverse cardiovascular events (MACE) up to 50 years of age, suggests a study.

Use of vedolizumab as maintenance treatment in children with inflammatory bowel disease (IBD) results in sustained steroid-free remission, with an acceptable safety profile, according to the results of the 54-week follow-up of the VedoKids Study presented at ESPGHAN 2024.

The risk of critical COVID-19 is highest among infants and adolescents, children with multiple comorbidities, those with a history of prematurity, diabetes, obesity, severe immunocompromise, and those with cardiovascular, neurologic, or chronic lung diseases, reveals a study presented at PAS 2024.